Activity of human recombinant CYP2C9 expressed in microsomes isolated from human AHH-1 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant CYP2C19 expressed in microsomes isolated from human AHH-1 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant CYP1A2 expressed in microsomes isolated from human AHH-1 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant CYP2A6 expressed in microsomes isolated from human AHH-1 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant CYP2B6 expressed in microsomes isolated from human AHH-1 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant CYP2E1 expressed in microsomes isolated from human AHH-1 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant CYP3A4 expressed in microsomes isolated from human AHH-1 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant FMO3 expressed in microsomes isolated from baculovirus infected insect BTI-TN-5B1-4 cells assessed as enzyme-mediated 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in phenotyped human liver microsomes assessed as formation of (3-methyl-4-(2-(piperazin-1-yl)phenylthio)phenyl)methanol at 8 to 50 uM after 60 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in phenotyped human liver microsomes assessed as formation of 3-methyl-4-(2-(piperazin-1-yl)phenylthio)benzoic acid at 8 to 50 uM after 60 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in phenotyped human liver microsomes assessed as formation of 1-(2-(2,4-dimethylphenylsulfinyl)phenyl)piperazine at 8 to 50 uM after 60 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in phenotyped human liver microsomes assessed as formation of 4-(2-(2,4-dimethylphenylthio)phenyl)piperazin-1-ol at 8 to 50 uM after 60 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in phenotyped human liver microsomes assessed as formation of 3-(2,4-dimethylphenylthio)-4-(piperazin-1-yl)phenol at 8 to 50 uM after 60 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant FMO3 expressed in microsomes isolated from baculovirus infected insect BTI-TN-5B1-4 cells assessed as enzyme-mediated 1-(2-(2,4-dimethylphenylsulfinyl)phenyl)piperazine formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant FMO3 expressed in microsomes isolated from baculovirus infected insect BTI-TN-5B1-4 cells assessed as enzyme-mediated 4-(2-(2,4-dimethylphenylthio)phenyl)piperazin-1-ol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant FMO3 expressed in microsomes isolated from baculovirus infected insect BTI-TN-5B1-4 cells assessed as enzyme-mediated 3-methyl-4-(2-(piperazin-1-yl)phenylthio)phenyl)methanol formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Activity of human recombinant FMO3 expressed in microsomes isolated from baculovirus infected insect BTI-TN-5B1-4 cells assessed as enzyme-mediated 3-methyl-4-(2-(piperazin-1-yl)phenylthio)benzoic acid formation at 8 to 50 uM after 120 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in pooled human liver microsomes assessed as formation of (3-methyl-4-(2-(piperazin-1-yl)phenylthio)phenyl)methanol at 100 uM after 30 to 180 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in pooled human liver microsomes assessed as formation of 3-methyl-4-(2-(piperazin-1-yl)phenylthio)benzoic acid at 100 uM after 30 to 180 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+
Drug metabolism in pooled human liver microsomes assessed as formation of 1-(2-(2,4-dimethylphenylsulfinyl)phenyl)piperazine at 100 uM after 30 to 180 mins by HPLC/MS-MS analysis in presence of NADPH regenerating system with NADP+